Acrylic Acid Methyl Ester

Acrylic Acid Methyl Ester

SCHEMBL258285

C=CC#N.C=CC(=O)OC

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 8/20 0.43
ALDH1A1 P00352 6/20 0.43
HCAR2 Q8TDS4 2/20 0.42
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
HPGD P15428 1/20 0.34
TP53 P04637 3/20 0.33
HIF1A Q16665 3/20 0.33
CYP3A4 P08684 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Methyl Ester SCHEMBL11204031 1.00 TSHR (0.43) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL11516777 1.00 TSHR (0.43) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL11366899 1.00 TSHR (0.43) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL11375074 1.00 TSHR (0.43) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL10891956 0.98 TSHR (0.41) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL7586379 0.96 TSHR (0.39) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL9246786 0.92 TSHR (0.36) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL27075753 0.92 TSHR (0.44) TSHRALDH1A1HCAR2KEAP1NFE2L2
Acrylic Acid Methyl Ester SCHEMBL27649119 0.90 TDP1 (0.42) TSHRALDH1A1HCAR2KEAP1NFE2L2
Maleic Acid SCHEMBL11028127 0.90 HCAR2 (0.54) TSHRALDH1A1HCAR2KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1343 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12532880-B2 Cryopreservation of cell monolayers Elliott, Janet Anne Wade (CA) 2026-01-27 US claimed
CN-115851151-B Expansion adhesive tape for lithium battery and preparation method thereof 广东东立新材料科技股份有限公司 2024-06-18 CN claimed
CN-114805708-B Polymer/Ag nano composite particle, preparation thereof and application thereof in preparation of durable antibacterial composite coating on hard substrate 浙江理工大学 2023-09-22 CN claimed
US-20230135608-A1 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER CURACLE CO., LTD. (KR) 2023-05-04 US claimed
EP-3616539-B1 CONTAINERS FOR AEROSOL-GENERATING DEVICES PHILIP MORRIS PRODUCTS SA (CH) 2023-04-05 EP claimed
CN-115851151-A Expansion adhesive tape for lithium battery and preparation method thereof 广东东立新材料科技股份有限公司 2023-03-28 CN claimed
CN-112812880-B Machining tool cutting fluid recycling method and application thereof 湖北凯梦科技有限公司 2023-03-10 CN claimed
WO-2022260073-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE 出光興産株式会社 2022-12-15 WO claimed
CN-112194320-B Treatment process of cutting fluid wastewater 伸荣(上海)水处理环保工程有限公司 2022-11-01 CN claimed
WO-2022203432-A1 PHARMACEUTICAL COMPOSITION, CONTAINING DIMETHYL FUMARATE AS ACTIVE INGREDIENT, SHOWING SPECIFIC PHARMACOKINETIC PARAMETER 주식회사 큐라클 2022-09-29 WO claimed
US-5715833-A Blood sampler Kleinhappl, Erich (AT) 1998-02-10 US claimed
US-5651462-A Rigid reclosable packaging REYNOLDS CONSUMER PRODUCTS INC. (US) 1997-07-29 US claimed
CN-1142944-A Coated capsule type medicinal preparation capable of releasing at lower part of alimentary canal TANABE SEIYAKU CO (JP) 1997-02-19 CN claimed
US-5324506-A Colored cosmetic compositions ESTEE LAUDER, INC. (US) 1994-06-28 US claimed
EP-0445342-B1 Colored cosmetic compositions ESTEE LAUDER INC (US) 1994-01-26 EP claimed
US-5143723-A Colored cosmetic compositions ESTEE LAUDER, INC. (US) 1992-09-01 US claimed
EP-0445342-A1 Colored cosmetic compositions ESTEE LAUDER INC. (US) 1991-09-11 EP claimed
US-4939040-A Foods, gas barrier W. R. GRACE & CO.-CONN. (US) 1990-07-03 US claimed
EP-0287942-A2 Multilayer film for packaging items under controlled atmosphere W.R. GRACE & CO. (US) 1988-10-26 EP claimed
US-4064315-A Maleic anhydride-modified polymer lager coated with polymeric composition derived from vinylidene chloride MOBIL OIL CORPORATION (US) 1977-12-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135608-A1 PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE AS AN ACTIVE INGREDIENT PROVIDES A SPECIFIC PHARMACOKINETIC PARAMETER SLC5A2, FH, SLC5A1 TSHR 4784/4885ALDH1A1 1455/4885HCAR2 894/4885
US-12532880-B2 Cryopreservation of cell monolayers EGLN1, VEGFA, LIPG TSHR 4104/4885ALDH1A1 2242/4885HCAR2 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.